SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors.
- Authors
- Goya, Rodrigo; Sun, Mark G F; Morin, Ryan D; Leung, Gillian; Ha, Gavin; Wiegand, Kimberley C; Senz, Janine; Crisan, Anamaria; Marra, Marco A; Hirst, Martin; Huntsman, David; Murphy, Kevin P; Aparicio, Sam; Shah, Sohrab P
- Year
- 2010
- Journal
- Bioinformatics (Oxford, England)
- PMID
- 20130035
- DOI
- 10.1093/bioinformatics/btq040
- PMCID
- PMC2832826
MOTIVATION: Next-generation sequencing (NGS) has enabled whole genome and transcriptome single nucleotide variant (SNV) discovery in cancer. NGS produces millions of short sequence reads that, once aligned to a reference genome sequence, can be interpreted for the presence of SNVs. Although tools exist for SNV discovery from NGS data, none are specifically suited to work with data from tumors, where altered ploidy and tumor cellularity impact the statistical expectations of SNV discovery. RESULTS: We developed three implementations of a probabilistic Binomial mixture model, called SNVMix, designed to infer SNVs from NGS data from tumors to address this problem. The first models allelic counts as observations and infers SNVs and model parameters using an expectation maximization (EM) algorithm and is therefore capable of adjusting to deviation of allelic frequencies inherent in genomically unstable tumor genomes. The second models nucleotide and mapping qualities of the reads by probabilistically weighting the contribution of a read/nucleotide to the inference of a SNV based on the confidence we have in the base call and the read alignment. The third combines filtering out low-quality data in addition to probabilistic weighting of the qualities. We quantitatively evaluated these approaches on 16 ovarian cancer RNASeq datasets with matched genotyping arrays and a human breast cancer genome sequenced to >40x (haploid) coverage with ground truth data and show systematically that the SNVMix models outperform competing approaches. AVAILABILITY: Software and data are available at http://compbio.bccrc.ca CONTACT: sshah@bccrc.ca SUPPLEMANTARY INFORMATION: Supplementary data are available at Bioinformatics online.
(A) Schematic diagram of input data to SNVMix1. We show how allelic counts (bottom) are derived from aligned reads (top). The reference sequence is shown indicated in blue. The arrows indicate positions representing SNVs. The non-reference bases are shown in red. (B) Input data for SNVMix2 that consists of the mapping and base qualities. The darker the background for a read represents a higher quality alignment. The brighter colored nucleotides represent higher quality base calls. Therefore, high contrast nucleotides are more trustworthy than lower contrast nucleotides. (C) SNVMix1 shown as a probabilistic graphical model. Circles represent random variables, and rounded squares represent fixed constants. Shaded notes indicate observed data [the allelic counts and the read depth from (A)]. Unshaded nodes indicate quantities that are inferred during EM. Giβ{aa, ab, bb} represents the genotype, Niβ{0, 1,β¦,} is the number of reads and aiβ{0, 1,β¦, Ni} is the number of reference reads. Ο is the prior over genotypes and ΞΌk is the genotype-specific Binomial parameter for genotype k. (D) SNVMix2 shown as a probabilistic graphical model. In comparison to SNVMix1, ai is unobserved and we expand the input to consider read-specific information indexed by j where zij=1 indicates that read j is correctly aligned, qij is the base quality and rij is the mapping quality.
(A) Theoretical behavior of SNVmix at depths of 2, 3, 5, 10, 15, 20, 35, 50 and 100. The plots show how the distribution of marginal probabilities changes with the number of reference alleles given the model parameters fit to a 10Γ breast cancer genome dataset. (B) ROC curves from fitting SNVMix2 to synthetic data with increasing levels of certainty in the base call.
Distribution of AUC over 16 ovarian cancer transcriptomes comparing accuracy of SNV detection for two Maq runs, the best and worst SNVMix1 runs in the cross-validation experiment (middle) and best and worst runs for SNVMix2 (mbQ0 = no quality thresholding, MbQ30 = keeping only reads with mapping qualities > Q30). SNVMix1 and SNVMix2 runs were statistically more accurate than both Maq runs (ANOVA, P < 0.0001). SNVMix2 runs were better than SNVMix1, but not statistically significantly.
| # | Section | Preview |
|---|---|---|
| 40 | 4 DISCUSSION β 4.2 Limitations, extensions and future work | Funding: The project is supported by the Canadian Institutes for Health Research (CIHR). SPS isβ¦ |
| 41 | 4 DISCUSSION β 4.2 Limitations, extensions and future work | Conflict of Interest: none declared. |
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Statistical modeling for sensitive detection of low-frequency single nucleotide variants. | 2016 | 27556804 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Advancing Non-Invasive Prenatal Screening: A Targeted 1069-Gene Panel for Comprehensive Detection of Monogenic Disorders and Copy Number Variations. | Sirica R et al. | β | 2025 | β |
| Application of artificial intelligence in laboratory hematology: Advances, challenges, and prospects. | Liao H et al. | β | 2025 | β |
| Noninvasive Prenatal Paternity Testing: A Review on Genetic Markers. | Carrara L et al. | β | 2025 | β |
| High-resolution mapping of Ryd4<sup>Hb</sup>, a major resistance gene to Barley yellow dwarf virus from Hordeum bulbosum. | Pidon H et al. | β | 2024 | β |
| The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma. | Shirai Y et al. | β | 2024 | β |
| Allelic expression imbalance in articular cartilage and subchondral bone refined genome-wide association signals in osteoarthritis. | Coutinho de Almeida R et al. | β | 2023 | β |
| Elucidating the process of SNPs identification in non-reference genome crops. | Sudan J et al. | β | 2023 | β |
| An Individualized Approach for Somatic Variant Discovery. | Li M et al. | β | 2020 | β |
| Identification of novel alternative transcripts of the human Ribonuclease ΞΊ (RNASEK) gene using 3' RACE and high-throughput sequencing approaches. | Adamopoulos PG et al. | β | 2020 | β |
| Noninvasive prenatal paternity testing by means of SNP-based targeted sequencing. | Tam JCW et al. | β | 2020 | β |
| Annotating Transcriptional Effects of Genetic Variants in Disease-Relevant Tissue: Transcriptome-Wide Allelic Imbalance in Osteoarthritic Cartilage. | den Hollander W et al. | β | 2019 | β |
| Calling Variants in the Clinic: Informed Variant Calling Decisions Based on Biological, Clinical, and Laboratory Variables. | Bohannan ZS et al. | β | 2019 | β |
| Cell-level somatic mutation detection from single-cell RNA sequencing. | Vu TN et al. | β | 2019 | β |
| Clinical Impact of Tumor Mutational Burden in Neuroblastoma. | Hwang WL et al. | β | 2019 | β |
| Lineage tracing using a Cas9-deaminase barcoding system targeting endogenous L1 elements. | Hwang B et al. | β | 2019 | β |
| novoCaller: a Bayesian network approach for de novo variant calling from pedigree and population sequence data. | Mohanty AK et al. | β | 2019 | β |
| Predicting chromosome 1p/19q codeletion by RNA expression profile: a comparison of current prediction models. | Wang ZL et al. | β | 2019 | β |
| Somatic mutation detection and classification through probabilistic integration of clonal population information. | Dorri F et al. | β | 2019 | β |
| Thirty years of neuroendocrinology: Technological advances pave the way for molecular discovery. | Stubbs FE et al. | β | 2019 | β |
| A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells. | Wolff A et al. | β | 2018 | β |
| A review of somatic single nucleotide variant calling algorithms for next-generation sequencing data. | Xu C | β | 2018 | β |
| Cancer transcriptome profiling at the juncture of clinical translation. | CieΕlik M et al. | β | 2018 | β |
| GrigoraSNPs: Optimized Analysis of SNPs for DNA Forensics. | Ricke DO et al. | β | 2018 | β |
| Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. | Grassi E et al. | β | 2018 | β |
| The present and future of de novo whole-genome assembly. | Sohn JI et al. | β | 2018 | β |
| Whole Exome Sequencing Identifies a Novel Hedgehog-Interacting Protein G516R Mutation in Locally Advanced Papillary Thyroid Cancer. | Lee WK et al. | β | 2018 | β |
| Are Next-Generation Sequencing Tools Ready for the Cloud? | Celesti A et al. | β | 2017 | β |
| Comprehensive benchmarking of SNV callers for highly admixed tumor data. | Bohnert R et al. | β | 2017 | β |
| Estimating error models for whole genome sequencing using mixtures of Dirichlet-multinomial distributions. | Wu SH et al. | β | 2017 | β |
| Genome-wide association and functional studies identify a role for matrix Gla protein in osteoarthritis of the hand. | den Hollander W et al. | β | 2017 | β |
| Identification of context-dependent expression quantitative trait loci in whole blood. | Zhernakova DV et al. | β | 2017 | β |
| sCNAphase: using haplotype resolved read depth to genotype somatic copy number alterations from low cellularity aneuploid tumors. | Chen W et al. | β | 2017 | β |
| Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia. | Sloma I et al. | β | 2017 | β |
| An Advanced Model to Precisely Estimate the Cell-Free Fetal DNA Concentration in Maternal Plasma. | Kang X et al. | β | 2016 | β |
| An empirical Bayes method for genotyping and SNP detection using multi-sample next-generation sequencing data. | Huang G et al. | β | 2016 | β |
| Estimation of genetic diversity in viral populations from next generation sequencing data with extremely deep coverage. | Zukurov JP et al. | β | 2016 | β |
| Medoidshift clustering applied to genomic bulk tumor data. | Roman T et al. | β | 2016 | β |
| Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress. | Oh S et al. | β | 2016 | β |
| Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing. | Parker JD et al. | β | 2016 | β |
| Monovar: single-nucleotide variant detection in single cells. | Zafar H et al. | β | 2016 | β |
| Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study. | Sheffield BS et al. | β | 2016 | β |
| Statistical modeling for sensitive detection of low-frequency single nucleotide variants. | Hao Y et al. | β | 2016 | β |
| The prediction of virus mutation using neural networks and rough set techniques. | Salama MA et al. | β | 2016 | β |
| A Comparison of Variant Calling Pipelines Using Genome in a Bottle as a Reference. | Cornish A et al. | β | 2015 | β |
| A simplicial complex-based approach to unmixing tumor progression data. | Roman T et al. | β | 2015 | β |
| Best practices for evaluating single nucleotide variant calling methods for microbial genomics. | Olson ND et al. | β | 2015 | β |
| Characterization and mapping of LanrBo: a locus conferring anthracnose resistance in narrow-leafed lupin (Lupinus angustifolius L.). | Fischer K et al. | β | 2015 | β |
| CRCDA--Comprehensive resources for cancer NGS data analysis. | Thangam M et al. | β | 2015 | β |
| Genetic inactivation of TRAF3 in canine and human B-cell lymphoma. | Bushell KR et al. | β | 2015 | β |
| Genome-wide analysis links NFATC2 with asparaginase hypersensitivity. | Fernandez CA et al. | β | 2015 | β |
| Genome-wide identification and characterization of tissue-specific RNA editing events in D. melanogaster and their potential role in regulating alternative splicing. | Mazloomian A et al. | β | 2015 | β |
| Mechanosensitive pannexin-1 channels mediate microvascular metastatic cell survival. | Furlow PW et al. | β | 2015 | β |
| multiSNV: a probabilistic approach for improving detection of somatic point mutations from multiple related tumour samples. | Josephidou M et al. | β | 2015 | β |
| Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us? | LeBlanc VG et al. | β | 2015 | β |
| Next-generation sequencing is a robust strategy for the high-throughput detection of zygosity in transgenic maize. | Fritsch L et al. | β | 2015 | β |
| The clonal relationships between pre-cancer and cancer revealed by ultra-deep sequencing. | Wood HM et al. | β | 2015 | β |
| A tool for mapping Single Nucleotide Polymorphisms using Graphics Processing Units. | Manconi A et al. | β | 2014 | β |
| CLImAT: accurate detection of copy number alteration and loss of heterozygosity in impure and aneuploid tumor samples using whole-genome sequencing data. | Yu Z et al. | β | 2014 | β |
| Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers. | Sun Z et al. | β | 2014 | β |
| Expanding the computational toolbox for mining cancer genomes. | Ding L et al. | β | 2014 | β |
| HapMuC: somatic mutation calling using heterozygous germ line variants near candidate mutations. | Usuyama N et al. | β | 2014 | β |
| Identification of recurrent SMO and BRAF mutations in ameloblastomas. | Sweeney RT et al. | β | 2014 | β |
| Inferring clonal composition from multiple sections of a breast cancer. | Zare H et al. | β | 2014 | β |
| Integrated RNA and DNA sequencing improves mutation detection in low purity tumors. | Wilkerson MD et al. | β | 2014 | β |
| Methods of quantifying microRNAs for hypoxia research: classic and next generation. | Radovich M et al. | β | 2014 | β |
| MOSAIK: a hash-based algorithm for accurate next-generation sequencing short-read mapping. | Lee WP et al. | β | 2014 | β |
| PAPNC, a novel method to calculate nucleotide diversity from large scale next generation sequencing data. | Shao W et al. | β | 2014 | β |
| RADIA: RNA and DNA integrated analysis for somatic mutation detection. | Radenbaugh AJ et al. | β | 2014 | β |
| Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma. | Gunawardana J et al. | β | 2014 | β |
| Subclonal variant calling with multiple samples and prior knowledge. | Gerstung M et al. | β | 2014 | β |
| The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data. | Tang X et al. | β | 2014 | β |
| TSSV: a tool for characterization of complex allelic variants in pure and mixed genomes. | Anvar SY et al. | β | 2014 | β |
| Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements. | Egan JB et al. | β | 2014 | β |
| A clinically validated diagnostic second-generation sequencing assay for detection of hereditary BRCA1 and BRCA2 mutations. | Bosdet IE et al. | β | 2013 | β |
| A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome. | Morris G et al. | β | 2013 | β |
| An integrated inspection of the somatic mutations in a lung squamous cell carcinoma using next-generation sequencing. | Stead LF et al. | β | 2013 | β |
| An integrated model of the transcriptome of HER2-positive breast cancer. | Kalari KR et al. | β | 2013 | β |
| A simple consensus approach improves somatic mutation prediction accuracy. | Goode DL et al. | β | 2013 | β |
| Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease. | Castellarin M et al. | β | 2013 | β |
| Comparing a few SNP calling algorithms using low-coverage sequencing data. | Yu X et al. | β | 2013 | β |
| Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia. | Atak ZK et al. | β | 2013 | β |
| Coval: improving alignment quality and variant calling accuracy for next-generation sequencing data. | Kosugi S et al. | β | 2013 | β |
| Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers. | Wang Q et al. | β | 2013 | β |
| Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS. | Folmes CD et al. | β | 2013 | β |
| Estimating exome genotyping accuracy by comparing to data from large scale sequencing projects. | Heinrich V et al. | β | 2013 | β |
| Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome. | Boczek NJ et al. | β | 2013 | β |
| Harnessing virtual machines to simplify next-generation DNA sequencing analysis. | Nocq J et al. | β | 2013 | β |
| Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. | DeRycke MS et al. | β | 2013 | β |
| Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs. | Christoforides A et al. | β | 2013 | β |
| Impact of library preparation on downstream analysis and interpretation of RNA-Seq data: comparison between Illumina PolyA and NuGEN Ovation protocol. | Sun Z et al. | β | 2013 | β |
| Joint genotype inference with germline and somatic mutations. | Bareke E et al. | β | 2013 | β |
| Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing. | O'Rawe J et al. | β | 2013 | β |
| Microbes, metagenomes and marine mammals: enabling the next generation of scientist to enter the genomic era. | Edwards RA et al. | β | 2013 | β |
| Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. | Morin RD et al. | β | 2013 | β |
| Next generation sequencing in cancer research and clinical application. | Shyr D et al. | β | 2013 | β |
| Next-generation sequencing in the clinic: promises and challenges. | Xuan J et al. | β | 2013 | β |
| Reliable identification of genomic variants from RNA-seq data. | Piskol R et al. | β | 2013 | β |
| SAVI: a statistical algorithm for variant frequency identification. | Trifonov V et al. | β | 2013 | β |
| SNVHMM: predicting single nucleotide variants from next generation sequencing. | Bian J et al. | β | 2013 | β |
| Somatic point mutation calling in low cellularity tumors. | Kassahn KS et al. | β | 2013 | β |
| The genetic landscape of high-risk neuroblastoma. | Pugh TJ et al. | β | 2013 | β |
| Virmid: accurate detection of somatic mutations with sample impurity inference. | Kim S et al. | β | 2013 | β |
| Whole-exome sequencing reveals recurrent somatic mutation networks in cancer. | Liu X et al. | β | 2013 | β |
| A fast and accurate SNP detection algorithm for next-generation sequencing data. | Xu F et al. | β | 2012 | β |
| A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. | Heit JA et al. | β | 2012 | β |
| Analyzing genomic data: understanding the genome | FernΓ‘ndez-SuΓ‘rez XM | β | 2012 | β |
| BCL2 mutations in diffuse large B-cell lymphoma. | Schuetz JM et al. | β | 2012 | β |
| Bioinformatics for cancer immunology and immunotherapy. | Charoentong P et al. | β | 2012 | β |
| BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma. | McAlpine JN et al. | β | 2012 | β |
| Clinical integration of next-generation sequencing technology. | Gullapalli RR et al. | β | 2012 | β |
| Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. | Yip S et al. | β | 2012 | β |
| Current status and future perspectives for sequencing livestock genomes. | Bai Y et al. | β | 2012 | β |
| Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations. | Kalari KR et al. | β | 2012 | β |
| Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma. | Zhou B et al. | β | 2012 | β |
| Feature-based classifiers for somatic mutation detection in tumour-normal paired sequencing data. | Ding J et al. | β | 2012 | β |
| FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma. | Jiang P et al. | β | 2012 | β |
| GenomeGems: evaluation of genetic variability from deep sequencing data. | Ben-Zvi S et al. | β | 2012 | β |
| Highly sensitive and specific detection of rare variants in mixed viral populations from massively parallel sequence data. | Macalalad AR et al. | β | 2012 | β |
| Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer. | Ha G et al. | β | 2012 | β |
| Joint genotyping on the fly: identifying variation among a sequenced panel of inbred lines. | Stone EA | β | 2012 | β |
| JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. | Roth A et al. | β | 2012 | β |
| lobSTR: A short tandem repeat profiler for personal genomes. | Gymrek M et al. | β | 2012 | β |
| Mutation discovery in regions of segmental cancer genome amplifications with CoNAn-SNV: a mixture model for next generation sequencing of tumors. | Crisan A et al. | β | 2012 | β |
| Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics. | Gullapalli RR et al. | β | 2012 | β |
| Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. | Heravi-Moussavi A et al. | β | 2012 | β |
| RNASEQR--a streamlined and accurate RNA-seq sequence analysis program. | Chen LY et al. | β | 2012 | β |
| SNP calling using genotype model selection on high-throughput sequencing data. | You N et al. | β | 2012 | β |
| SomaticSniper: identification of somatic point mutations in whole genome sequencing data. | Larson DE et al. | β | 2012 | β |
| Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. | Saunders CT et al. | β | 2012 | β |
| The allele distribution in next-generation sequencing data sets is accurately described as the result of a stochastic branching process. | Heinrich V et al. | β | 2012 | β |
| TREAT: a bioinformatics tool for variant annotations and visualizations in targeted and exome sequencing data. | Asmann YW et al. | β | 2012 | β |
| Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. | Kridel R et al. | β | 2012 | β |
| Blood ties: chimerism can mask twin discordance in high-throughput sequencing. | Erlich Y | β | 2011 | β |
| Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis. | Erlich Y et al. | β | 2011 | β |
| Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. | Morin RD et al. | β | 2011 | β |
| GAMES identifies and annotates mutations in next-generation sequencing projects. | Sana ME et al. | β | 2011 | β |
| Innovative technology for cancer risk analysis. | Tommasi S et al. | β | 2011 | β |
| Next-generation sequencing for cancer diagnostics: a practical perspective. | Meldrum C et al. | β | 2011 | β |
| Next generation sequencing has lower sequence coverage and poorer SNP-detection capability in the regulatory regions. | Wang W et al. | β | 2011 | β |
| Segtor: rapid annotation of genomic coordinates and single nucleotide variations using segment trees. | Renaud G et al. | β | 2011 | β |
| SeqGene: a comprehensive software solution for mining exome- and transcriptome- sequencing data. | Deng X | β | 2011 | β |
| Statistical inference of allelic imbalance from transcriptome data. | Nothnagel M et al. | β | 2011 | β |
| Targeted assembly of short sequence reads. | Warren RL et al. | β | 2011 | β |
| Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. | Brownstein Z et al. | β | 2011 | β |
| Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalities. | Schrader KA et al. | β | 2011 | β |
| Advances in understanding cancer genomes through second-generation sequencing. | Meyerson M et al. | β | 2010 | β |
| Analysis of next-generation genomic data in cancer: accomplishments and challenges. | Ding L et al. | β | 2010 | β |
| Application of second-generation sequencing to cancer genomics. | Robison K | β | 2010 | β |
| ARID1A mutations in endometriosis-associated ovarian carcinomas. | Wiegand KC et al. | β | 2010 | β |
| Statistical Analyses of Next Generation Sequence Data: A Partial Overview. | Datta S et al. | β | 2010 | β |